Format
Sort by
Items per page

Send to

Choose Destination

Best matches for hypomagnesemia AND ("QT" OR Torsad*):

Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management. Tisdale JE et al. Can Pharm J (Ott). (2016)

Channelopathies. Kim JB et al. Korean J Pediatr. (2014)

Risk factors for QTc-prolongation: systematic review of the evidence. Vandael E et al. Int J Clin Pharm. (2017)

Search results

Items: 1 to 20 of 117

1.

Persistent QT Prolongation in a Child with Gitelman Syndrome and SCN5A H558R Polymorphism.

Tsukakoshi T, Lin L, Murakami T, Shiono J, Izumi I, Horigome H.

Int Heart J. 2018 Nov 28;59(6):1466-1468. doi: 10.1536/ihj.17-686. Epub 2018 Oct 10.

PMID:
30305584
Free Article
2.

Hypomagnesemia and hypermagnesemia.

Van Laecke S.

Acta Clin Belg. 2018 Sep 17:1-7. doi: 10.1080/17843286.2018.1516173. [Epub ahead of print]

PMID:
30220246
3.

Predictive Analytics for Identification of Patients at Risk for QT Interval Prolongation: A Systematic Review.

Tomaselli Muensterman E, Tisdale JE.

Pharmacotherapy. 2018 Aug;38(8):813-821. doi: 10.1002/phar.2146. Epub 2018 Jul 18. Review.

PMID:
29882591
4.

Proton Pump Inhibitors and Serum Magnesium Levels in Patients With Torsades de Pointes.

Lazzerini PE, Bertolozzi I, Finizola F, Acampa M, Natale M, Vanni F, Fulceri R, Gamberucci A, Rossi M, Giabbani B, Caselli M, Lamberti I, Cevenini G, Laghi-Pasini F, Capecchi PL.

Front Pharmacol. 2018 Apr 20;9:363. doi: 10.3389/fphar.2018.00363. eCollection 2018.

5.

The effects of zoledronic acid on ECG: a prospective study on patients with bone metastatic cancer.

Demirtas D, Bilir C, Demirtas AO, Engin H.

Clin Cases Miner Bone Metab. 2017 Jan-Apr;14(1):35-39. doi: 10.11138/ccmbm/2017.14.1.035. Epub 2017 May 30.

6.

[Magnesium in daily practice].

Minetto D, Serratrice J, Stirnemann J.

Rev Med Suisse. 2016 Oct 19;12(535):1761-1765. French.

PMID:
28692217
7.

Risk factors for QTc-prolongation: systematic review of the evidence.

Vandael E, Vandenberk B, Vandenberghe J, Willems R, Foulon V.

Int J Clin Pharm. 2017 Feb;39(1):16-25. doi: 10.1007/s11096-016-0414-2. Epub 2016 Dec 23. Review.

PMID:
28012118
8.

Reckless administration of QT interval-prolonging agents in elderly patients with drug-induced torsade de pointes.

Jackobson G, Carmel NN, Lotan D, Kremer A, Justo D.

Z Gerontol Geriatr. 2018 Jan;51(1):41-47. doi: 10.1007/s00391-016-1155-5. Epub 2016 Nov 22.

PMID:
27878411
9.

Association of Serum Magnesium on Mortality in Patients Admitted to the Intensive Cardiac Care Unit.

Naksuk N, Hu T, Krittanawong C, Thongprayoon C, Sharma S, Park JY, Rosenbaum AN, Gaba P, Killu AM, Sugrue AM, Peeraphatdit T, Herasevich V, Bell MR, Brady PA, Kapa S, Asirvatham SJ.

Am J Med. 2017 Feb;130(2):229.e5-229.e13. doi: 10.1016/j.amjmed.2016.08.033. Epub 2016 Sep 14.

PMID:
27639872
10.

Hypomagnesemia as a potentially life-threatening adverse effect of omeprazole.

Hansen BA, Bruserud Ø.

Oxf Med Case Reports. 2016 Jul 27;2016(7):147-9. doi: 10.1093/omcr/omw062. eCollection 2016 Jul.

11.

Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management.

Tisdale JE.

Can Pharm J (Ott). 2016 May;149(3):139-52. doi: 10.1177/1715163516641136. Epub 2016 Apr 8. Review.

12.

Severe Torsades de Pointes with acquired QT prolongation.

Narang A, Ozcan C.

Eur Heart J Acute Cardiovasc Care. 2016 May 6. pii: 2048872616649473. [Epub ahead of print]

PMID:
27154527
13.

An approach to the diagnosis and management of a case presenting with recurrent hypomagnesemia secondary to the chronic use of a proton pump inhibitor.

dos Santos LM, Guerra RA, Lazaretti-Castro M, Vieira JG, Portes Ede S, Dias-da-Silva MR.

Magnes Res. 2015 Dec;28(4):136-45. doi: 10.1684/mrh.2015.0395.

14.

Abnormal repolarization dynamics in a patient with KCNE1(G38S) who presented with torsades de pointes.

Yamaguchi Y, Mizumaki K, Hata Y, Inoue H.

J Electrocardiol. 2016 Jan-Feb;49(1):94-8. doi: 10.1016/j.jelectrocard.2015.10.002. Epub 2015 Oct 14.

PMID:
26520166
15.

Magnesium and Dialysis: The Neglected Cation.

Alhosaini M, Leehey DJ.

Am J Kidney Dis. 2015 Sep;66(3):523-31. doi: 10.1053/j.ajkd.2015.01.029. Epub 2015 Apr 9. Review.

PMID:
25864370
16.

Hypomagnesemic down-regulation of L-type Ca(2+) channel in cardiomyocyte as an arrhythmogenic substrate in rats.

Shimaoka T, Wang Y, Morishima M, Miyamoto S, Ono K.

Pathophysiology. 2015 Jun;22(2):87-93. doi: 10.1016/j.pathophys.2015.01.002. Epub 2015 Feb 8.

PMID:
25701242
17.

Analysis of an ECG record database reveals QT interval prolongation potential of famotidine in a large Korean population.

Yun J, Hwangbo E, Lee J, Chon CR, Kim PA, Jeong IH, Park M, Park R, Kang SJ, Choi D.

Cardiovasc Toxicol. 2015 Apr;15(2):197-202. doi: 10.1007/s12012-014-9285-8.

PMID:
25253561
18.

Hypomagnesemia in the intensive care unit: Choosing your gastrointestinal prophylaxis, a case report and review of the literature.

Wang AK, Sharma S, Kim P, Mrejen-Shakin K.

Indian J Crit Care Med. 2014 Jul;18(7):456-60. doi: 10.4103/0972-5229.136075.

19.

Quetiapine, QTc interval prolongation, and torsade de pointes: a review of case reports.

Hasnain M, Vieweg WV, Howland RH, Kogut C, Breden Crouse EL, Koneru JN, Hancox JC, Digby GC, Baranchuk A, Deshmukh A, Pandurangi AK.

Ther Adv Psychopharmacol. 2014 Jun;4(3):130-8. doi: 10.1177/2045125313510194. Review.

20.

Increasing gap junction coupling suppresses ibutilide-induced torsades de pointes.

Ruan L, Quan X, Li L, Bai R, Ni M, Xu R, Zhang C.

Exp Ther Med. 2014 May;7(5):1279-1284. Epub 2014 Mar 4.

Supplemental Content

Loading ...
Support Center